EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pall's Enterprise Value is €11,813 Mil.
Pall's EBIT for the trailing twelve months (TTM) ended in Apr. 2015 was €422 Mil. Therefore, Pall's EV-to-EBIT for today is 27.97.
The historical rank and industry rank for Pall's EV-to-EBIT or its related term are showing as below:
FRA:PA5'
s EV-to-EBIT Range Over the Past 10 Years
Min: 7.9 Med: 16.8 Max: 27
Current: 26.55
During the past 13 years, the highest EV-to-EBIT of Pall was 27.00. The lowest was 7.90. And the median was 16.80.
FRA:PA5's EV-to-EBIT is not ranked
in the Industrial Products industry.
Industry Median: 16.955
vs FRA:PA5: 26.55
The historical data trend for Pall's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Pall's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pall's EV-to-EBIT Distribution in the Industrial Products Industry
For the Industrial Products industry and Industrials sector, Pall's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Pall's EV-to-EBIT falls into.
Pall's current Enterprise Value is €11,813 Mil.
Pall's EBIT for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €422 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pall (FRA:PA5) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Pall's Enterprise Value for the quarter that ended in Apr. 2015 was €9,862 Mil.
Pall's EBIT for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €422 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pall EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Pall's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Pall Corporation is a New York corporation incorporated on July 31, 1946. The Company supplies filtration, separation and purification technologies. Its products are used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases. Its serves its customers through two businesses: Life Sciences and Industrial. The Life Sciences business group is engaged in developing, manufacturing and selling products to customers in the BioPharmaceutical, Food & Beverage and Medical markets. The Industrial business group is engaged in developing, manufacturing and selling products to customers in the Process Technologies, Aerospace and Microelectronics markets. The Life Sciences technologies facilitate the process of drug discovery, development, regulatory validation and production, and are used in research laboratories, and the pharmaceutical and biotechnology industries. It also supplies products and technologies for food and beverage industries and in hospitals at the point of patient care. The Industrial segment provides enabling and process-enhancing technologies throughout the industrial marketplace. These include the Process Technologies, Aerospace and Microelectronics markets. It has the capability to provide customers with integrated solutions using its proprietary consumable filtration products for their process fluids. The Company's competition varies by product and application. Its competitors in the BioPharmaceuticals market include Merck Millipore (a division of Merck KGaA), The Sartorius Group and GE Healthcare (a unit of General Electric Company ("GE")). Its competitors in the Food & Beverage market include 3M Purification, Pentair, Inc., Filtrox Group, The Sartorius Group, Eaton Corporation and Parker Domnick Hunter (a division of Parker Hannifin). Its competitors in the Medical market include Merck Millipore, GE Healthcare, Teleflex Incorporated, Covidien plc and Intersurgical, Ltd. Its competitors in the Process Technologies market include CLARCOR Inc., Donaldson Company, Inc., Parker Hannifin Corporation, HYDAC International GmbH, GE Infrastructure (a unit of GE), Pentair, Inc., 3M Purification, U.S. Filter (a unit of Siemens AG) and ESCO Technologies Inc. Its competitors in the Aerospace market include Donaldson Company, Inc. and ESCO Technologies Inc. Its competitors in the Microelectronics market include Entegris, Inc., Parker Hannifin Corporation and Mott Corporation. The Company is subject to competition in all of the global markets in which it operates.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PA5 has been successfully added to your 